Unknown

Dataset Information

0

Lentiviral hematopoietic stem cell gene therapy in patients with Wiskott-Aldrich syndrome.


ABSTRACT: Wiskott-Aldrich syndrome (WAS) is an inherited immunodeficiency caused by mutations in the gene encoding WASP, a protein regulating the cytoskeleton. Hematopoietic stem/progenitor cell (HSPC) transplants can be curative, but, when matched donors are unavailable, infusion of autologous HSPCs modified ex vivo by gene therapy is an alternative approach. We used a lentiviral vector encoding functional WASP to genetically correct HSPCs from three WAS patients and reinfused the cells after a reduced-intensity conditioning regimen. All three patients showed stable engraftment of WASP-expressing cells and improvements in platelet counts, immune functions, and clinical scores. Vector integration analyses revealed highly polyclonal and multilineage haematopoiesis resulting from the gene-corrected HSPCs. Lentiviral gene therapy did not induce selection of integrations near oncogenes, and no aberrant clonal expansion was observed after 20 to 32 months. Although extended clinical observation is required to establish long-term safety, lentiviral gene therapy represents a promising treatment for WAS.

SUBMITTER: Aiuti A 

PROVIDER: S-EPMC4375961 | biostudies-literature | 2013 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

Lentiviral hematopoietic stem cell gene therapy in patients with Wiskott-Aldrich syndrome.

Aiuti Alessandro A   Biasco Luca L   Scaramuzza Samantha S   Ferrua Francesca F   Cicalese Maria Pia MP   Baricordi Cristina C   Dionisio Francesca F   Calabria Andrea A   Giannelli Stefania S   Castiello Maria Carmina MC   Bosticardo Marita M   Evangelio Costanza C   Assanelli Andrea A   Casiraghi Miriam M   Di Nunzio Sara S   Callegaro Luciano L   Benati Claudia C   Rizzardi Paolo P   Pellin Danilo D   Di Serio Clelia C   Schmidt Manfred M   Von Kalle Christof C   Gardner Jason J   Mehta Nalini N   Neduva Victor V   Dow David J DJ   Galy Anne A   Miniero Roberto R   Finocchi Andrea A   Metin Ayse A   Banerjee Pinaki P PP   Orange Jordan S JS   Galimberti Stefania S   Valsecchi Maria Grazia MG   Biffi Alessandra A   Montini Eugenio E   Villa Anna A   Ciceri Fabio F   Roncarolo Maria Grazia MG   Naldini Luigi L  

Science (New York, N.Y.) 20130711 6148


Wiskott-Aldrich syndrome (WAS) is an inherited immunodeficiency caused by mutations in the gene encoding WASP, a protein regulating the cytoskeleton. Hematopoietic stem/progenitor cell (HSPC) transplants can be curative, but, when matched donors are unavailable, infusion of autologous HSPCs modified ex vivo by gene therapy is an alternative approach. We used a lentiviral vector encoding functional WASP to genetically correct HSPCs from three WAS patients and reinfused the cells after a reduced-i  ...[more]

Similar Datasets

| S-EPMC4607131 | biostudies-literature
| S-EPMC2789278 | biostudies-literature
| S-EPMC3064520 | biostudies-literature
| S-EPMC4559137 | biostudies-literature
| S-EPMC6721834 | biostudies-literature
| S-EPMC3362358 | biostudies-literature
| S-EPMC4449020 | biostudies-literature
| S-EPMC3378501 | biostudies-literature
| S-EPMC5363182 | biostudies-literature
| S-EPMC4942841 | biostudies-literature